Philip Morris International Currently Up Eight Consecutive Days, on Pace for Longest Winning Streak Since November 2022 — Data Talk
Philip Morris International Inc. (PM) is currently at $95.44, up $0.77 or 0.81%
--Would be highest close since Jan. 9, 2024, when it closed at $95.59
--Currently up eight consecutive days; up 6.24% over this period
--Longest winning streak since Nov. 25, 2022, when it rose for eight straight trading days
--Best eight day stretch since the eight days ending April 6, 2023, when it rose 6.94%
--Up 6.09% month-to-date
--Up 1.44% year-to-date
--Down 22.35% from its all-time closing high of $122.90 on June 19, 2017
--Down 0.77% from 52 weeks ago (March 15, 2023), when it closed at $96.18
--Down 5.98% from its 52-week closing high of $101.51 on April 19, 2023
--Up 9.11% from its 52-week closing low of $87.47 on Oct. 27, 2023
--Traded as high as $95.87; highest intraday level since Jan. 12, 2024, when it hit $96.41
--Up 1.27% at today's intraday high
All data as of 11:14:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 13, 2024 11:32 ET (15:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Should Emerging-Markets Stocks Stand Alone in Your Portfolio?
-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
3 Dividend Stocks for October 2024
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued